We are live on ! Find out more

48 hedge funds and large institutions have $1.79M invested in BioVie in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

2% less funds holding

Funds holding: 49 → 48 (-1)

4.9% less ownership

Funds ownership: 12.21% → 7.31% (-4.9%)

13% less call options, than puts

Call options by funds: $14K | Put options by funds: $16K

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

82% less capital inflows, than outflows

Capital inflows: $235K | Capital outflows: $1.34M

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
7
Reduced
17
Closed
12
Calls
$14​K
Puts
$16​K
Net Calls
-⁠$2​K
Net Calls Change
+$182​K

BIVI Hedge Fund Activity: Q2 2024 in Review

48 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2024, worth a combined $1.79M — down 50% from $3.55M a quarter earlier.

Fund positioning in BIVI was balanced in Q2 2024: 12 funds opened new positions, 12 closed out, 7 added to existing stakes and 17 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $84.3K. The largest seller was Altium Capital Management, cutting an estimated $493K.

  • 48 institutional investors held BioVie (BIVI) as of Q2 2024, down from 49 in Q1 2024.
  • Funds reported $1.79M of BioVie stock for Q2 2024, down 50% quarter-over-quarter.
  • 12 funds opened new BioVie positions in Q2 2024 and 12 closed out, a net change of 0 holders.
  • The largest BioVie buyer in Q2 2024 was Jane Street, an estimated $84.3K added.
  • The largest BioVie seller in Q2 2024 was Altium Capital Management, an estimated $493K sold.

Based on aggregated 13F filings for Q2 2024.